Why might a false positive serologic test for Lyme disease occur

Why might a false positive serologic test for Lyme disease occur?

• Adequately treated patients may remain seropositive for many years after an infection is eradicated. Furthermore, individuals who live in endemic areas are more likely to have had a subclinical infection in the past and may also be seropositive.

• Antibodies directed toward other spirochetes may cross-react to the Borrelia antigen(s) used in ELISA. This scenario should be considered in a patient with over 1 month of nonspecific symptoms and a positive IgM ELISA, but a negative IgG ELISA (since patients with Lyme disease should develop an IgG response within this time period). This can occur in syphilis, leptospirosis, tick-borne relapsing fever, or with exposure to Treponema denticola (a spirochete found in the oral cavity) during a dental procedure.

• Cross-reactivity may occur in other conditions including granulocytic anaplasmosis, Helicobacter pylori infections, bacterial endocarditis, and autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis.

• Nonspecific polyclonal B-cell activation in Epstein–Barr virus, cytomegalovirus, and malaria may also produce cross-reactive antibodies.

• The use of unvalidated methods for interpretation of Western blots may lead to false-positive results. This may be due to an erroneous scoring of a faint band, more often an issue with IgM blots than IgG blots.

Due to these limitations, Lyme testing should only be used to confirm the diagnosis in patients with a compatible clinical presentation and should be avoided as a screening method in patients who have multiple vague complaints.


Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

Scroll to Top